Reports are emerging about the effects of stopping GLP-1 weight loss drugs, with some outlets suggesting that users may experience weight regain. The impact of discontinuing these medications, including Ozempic and Wegovy, is being explored, but it appears that many users are uncertain about what to expect. Research on the topic is ongoing, with experts and studies offering insights into the potential consequences of stopping GLP-1 treatment.